JPM vs MIN
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
MIN presents a conflicting profile where a stable Piotroski F-Score of 5/9 and a Graham Number of $3.14 suggest underlying value, but fundamental growth is in collapse. The trust is experiencing a severe earnings contraction of -40.90% and is paying out 146.81% of its earnings as dividends, which is unsustainable. With a technical trend of 0/100 and an intrinsic value of $1.12, the current price of $2.48 appears supported only by a declining dividend yield rather than organic growth.
Compare Another Pair
Related Comparisons
JPM vs MIN: Head-to-Head Comparison
This page compares JPMorgan Chase & Co. (JPM) and MFS Intermediate Income Trust (MIN) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.